Targeted therapies of chronic myeloid leukemia (CML) using tyrosine kinase inhibitors (TKI)
have profoundly changed the natural history of the disease with a major impact on survival …

Angiogenesis is defined as the formation of new capillaries from preexisting blood vessels
and plays an important role in the progression of solid tumors. Recently a similar …

Purpose Malignant cells are genetically unstable and prone to develop chemotherapy
resistance, whereas tumor vasculature is usually of host origin and genetically stable. Tumor …

The field of cell‐based transplantation has expanded considerably and is poised to become
an established cardiovascular therapy in the near future. In this review, we will focus on …

Chronic myeloid leukemia (CML) has been studied intensively for many years; yet its
treatment remains problematic and its biology remains elusive. In chronic phase, the …

The mechanism underlying the immunological advantage of hepatic allografts relative to
other organs is incompletely understood. We used molecular probes for the repetitive units …

Endothelial progenitor cells (EPCs) are a cell population mobilized from bone marrow into
the peripheral circulation and recruited into sites of vessel injury to participate in blood …

Chronic myeloid leukemia (CML) is sustained by a rare population of primitive, quiescent,
BCR-ABL+ cells and represents an excellent example of a malignancy in which tumor …

Neoangiogenesis is crucial for solid tumor growth and invasion, as the vasculature provides
metabolic support and access to the circulation. Current antiangiogenic therapies have been …

Latent cytomegalovirus (CMV) is frequently transmitted by organ transplantation, and its
reactivation under conditions of immunosuppressive prophylaxis against graft rejection by …